CentreStone Ventures

About The Fund

CentreStone Ventures is a life sciences focused private venture capital fund based in Winnipeg, Manitoba, Canada. They specialize in investing primarily in companies that are developing early-stage therapeutics, medical devices, diagnostics, and new drug delivery methods. CentreStone Ventures targets companies that are addressing large markets with unmet clinical needs. Their investment interest lies in businesses that boast technologies underpinned by solid intellectual property and that combine entrepreneurial and technical expertise, with the trajectory to become market leaders. Positioned at the geographic center of North America, the fund has strategic access to investment opportunities that emerge from leading research centers not only within their focus area of Western Canada and the U.S. Midwest but across the continent. CentreStone Ventures goes beyond providing capital by actively partnering with scientific entrepreneurs. They support the growth of these companies by providing the necessary structure, guidance, and support to create a robust foundation for commercial development. The team at CentreStone includes industry experts like Dr. Albert D. Friesen, who has founded health industry companies and established several GMP production facilities, and Mr. Marcus Enns and Mr. James Kinley who have extensive experience in corporate finance and financial operations, respectively. They put a strong emphasis on building companies that can lead in the life sciences sector and contribute to the health industry through innovative solutions.